Burke & Herbert Financial institution & Agree with Co. lowered its stake in stocks of Johnson & Johnson (NYSE:JNJ – Unfastened Record) by way of 18.4% within the third quarter, HoldingsChannel studies. The institutional investor owned 22,909 stocks of the corporate’s inventory after promoting 5,164 stocks all through the quarter. Johnson & Johnson accounts for about 2.9% of Burke & Herbert Financial institution & Agree with Co.’s funding portfolio, making the inventory its sixth greatest maintaining. Burke & Herbert Financial institution & Agree with Co.’s holdings in Johnson & Johnson have been price $3,568,000 on the finish of the latest quarter.

A number of different institutional traders and hedge price range have additionally made adjustments to their positions within the inventory. BlackRock Inc. lifted its stake in stocks of Johnson & Johnson by way of 1.4% all through the primary quarter. BlackRock Inc. now owns 201,491,567 stocks of the corporate’s inventory price $31,231,193,000 after purchasing an extra 2,688,798 stocks all through the duration. State Side road Corp lifted its stake in stocks of Johnson & Johnson by way of 1.1% all through the second one quarter. State Side road Corp now owns 141,833,756 stocks of the corporate’s inventory price $23,476,323,000 after purchasing an extra 1,568,633 stocks all through the duration. Moneta Staff Funding Advisors LLC raised its holdings in stocks of Johnson & Johnson by way of 90,144.4% all through the fourth quarter. Moneta Staff Funding Advisors LLC now owns 54,386,720 stocks of the corporate’s inventory price $9,607,414,000 after buying an extra 54,326,454 stocks all through the remaining quarter. Geode Capital Control LLC raised its holdings in stocks of Johnson & Johnson by way of 2.0% all through the second one quarter. Geode Capital Control LLC now owns 49,697,798 stocks of the corporate’s inventory price $8,203,608,000 after buying an extra 990,298 stocks all through the remaining quarter. After all, Morgan Stanley raised its holdings in stocks of Johnson & Johnson by way of 12.0% all through the fourth quarter. Morgan Stanley now owns 42,224,521 stocks of the corporate’s inventory price $7,458,962,000 after buying an extra 4,521,062 stocks all through the remaining quarter. 68.40% of the inventory is recently owned by way of institutional traders and hedge price range.

Analyst Rankings Adjustments

A number of brokerages not too long ago issued studies on JNJ. Cantor Fitzgerald reissued an “obese” ranking on stocks of Johnson & Johnson in a file on Monday, December 18th. Wells Fargo & Corporate minimize stocks of Johnson & Johnson from an “obese” ranking to an “equivalent weight” ranking and lowered their goal fee for the inventory from $170.00 to $163.00 in a file on Wednesday, December thirteenth. TheStreet minimize stocks of Johnson & Johnson from a “b” ranking to a “c+” ranking in a file on Friday, November seventeenth. Royal Financial institution of Canada reissued an “outperform” ranking and set a $178.00 goal fee on stocks of Johnson & Johnson in a file on Friday, December 1st. After all, Raymond James minimize their fee purpose on stocks of Johnson & Johnson from $179.00 to $172.00 and set an “outperform” ranking for the corporate in a file on Wednesday, October 18th. 8 analysis analysts have rated the inventory with a hang ranking, six have assigned a purchase ranking and one has issued a powerful purchase ranking to the corporate. In response to information from MarketBeat, Johnson & Johnson recently has a mean ranking of “Reasonable Purchase” and a consensus goal fee of $168.75.

Learn Our Newest Inventory Record on JNJ

Johnson & Johnson Inventory Up 0.2 %

Stocks of NYSE JNJ opened at $156.61 on Friday. The corporate’s 50-day easy shifting reasonable is $152.48 and its 200-day easy shifting reasonable is $159.60. Johnson & Johnson has a 52-week low of $144.95 and a 52-week prime of $180.93. The company has a marketplace cap of $377.00 billion, a price-to-earnings ratio of eleven.63, a price-to-earnings-growth ratio of three.20 and a beta of 0.57. The corporate has a handy guide a rough ratio of 0.96, a present ratio of one.21 and a debt-to-equity ratio of 0.37.

Johnson & Johnson (NYSE:JNJ – Get Unfastened Record) remaining introduced its income effects on Tuesday, October seventeenth. The corporate reported $2.66 income according to percentage (EPS) for the quarter, beating the consensus estimate of $2.52 by way of $0.14. Johnson & Johnson had a web margin of 36.32% and a go back on fairness of 37.14%. The trade had earnings of $21.35 billion for the quarter, in comparison to analyst estimates of $21 billion. Equities analysts expect that Johnson & Johnson will submit 9.96 EPS for the present fiscal yr.

Johnson & Johnson Declares Dividend

The trade additionally not too long ago introduced a quarterly dividend, which was once paid on Tuesday, December fifth. Stockholders of report on Tuesday, November twenty first got a $1.19 dividend. The ex-dividend date of this dividend was once Monday, November twentieth. This represents a $4.76 annualized dividend and a dividend yield of three.04%. Johnson & Johnson’s dividend payout ratio (DPR) is 35.34%.

Johnson & Johnson Profile

(Unfastened Record)

Johnson & Johnson, in conjunction with its subsidiaries, researches, develops, manufactures, and sells quite a lot of merchandise within the healthcare box international. The corporate’s Client Well being phase supplies pores and skin well being/good looks merchandise underneath the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX manufacturers; child care merchandise underneath the JOHNSON’S and AVEENO Child manufacturers; oral care merchandise underneath the LISTERINE emblem; TYLENOL acetaminophen merchandise; SUDAFED chilly, flu, and allergic reaction merchandise; BENADRYL and ZYRTEC allergic reaction merchandise; MOTRIN IB ibuprofen merchandise; NICORETTE smoking cessation merchandise; and PEPCID acid reflux disorder merchandise.

Additional Studying

Need to see what different hedge price range are maintaining JNJ? Seek advice from HoldingsChannel.com to get the most recent 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ – Unfastened Record).

Obtain Information & Rankings for Johnson & Johnson Day-to-day – Input your e-mail cope with underneath to obtain a concise day-to-day abstract of the most recent information and analysts’ scores for Johnson & Johnson and comparable firms with MarketBeat.com’s FREE day-to-day e-mail e-newsletter.